The Intramural Research Program of the National Institute on Drug Abuse

Skip Navigation

A figure from this study.
Study authors Sam Golden
and Conor Heins
Featured paper of the Month!

Compulsive Addiction-like Aggressive Behavior in Mice.

Biol Psychiatry. 2017 Aug 15;82(4):239-248. doi: 10.1016/j.biopsych.2017.03.004. Epub 2017 Mar 17.

Golden SA, Heins C, Venniro M, Caprioli D, Zhang M, Epstein DH, Shaham Y.

Some people are highly motivated to seek aggressive encounters, and among those who have been incarcerated for such behavior, recidivism rates are high. These observations echo two core features of drug addiction: high motivation to seek addictive substances, despite adverse consequences, and high relapse rates. Here we used established rodent models of drug addiction to determine whether they would be sensitive to "addiction-like" features of aggression in CD-1 mice...

More about this paper on PubMed

A figure from this article.
A figure from this article.
Reviews to Read

Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases.

J Biomed Sci. 2017 Sep 16;24(1):74. doi: 10.1186/s12929-017-0380-6. Review.

Weng TY, Tsai SA, Su TP.

The sigma-1 receptor (Sig-1R) is a chaperone that resides mainly at the mitochondrion-associated endoplasmic reticulum (ER) membrane (called the MAMs) and acts as a dynamic pluripotent modulator in living systems. At the MAM, the Sig-1R is known to play a role in regulating the Ca2+ signaling between ER and mitochondria and in maintaining the structural integrity of the MAM....

You can read more about this paper on PubMed.

Dr. Jeremy P. Waletzky

Dr. Jeremy P. Waletzky

NIDA IRP NEWS!

Dr. Jeremy P. Waletzky Event

This event will take place at the NIDA IRP, in the Atrium of the Biomedical Research Center on the Johns Hopkins Bayview campus in Baltimore on November 9, 2017. The event will feature a variety of speakers discussing addiction and neuroscience well as an award presentation for Dr. Waletzky.

Full Event Schedule Here.

A figure from this study.
A figure from this study.
Featured paper of the Month!

Salience and default mode network dysregulation in chronic cocaine users predict treatment outcome.

Brain. 2017 Feb 20. doi: 10.1093/brain/awx036. [Epub ahead of print]

Geng X, Hu Y, Gu H, Salmeron BJ, Adinoff B, Stein EA, Yang Y.

The goal of the study was to identify imaging biomarkers that predict the treatment outcome of cocaine addiction. Impairments of cortical thickness and functional connectivity were identified in a cohort of non-treatment-seeking cocaine users compared with matched healthy controls. These brain structural and functional measures were used, together with clinical assessments and demographic information, to predict treatment outcome of a separate cohort of treatment-seeking cocaine users who underwent a residential psychosocial treatment . Functional connectivity between the temporal pole (TP) and medial prefrontal cortex (mPFC), together with years of education, predicted the treatment outcome at an accuracy up to 88% at 150 days after the discharge from the treatment. The TP-mPFC circuit identified in this study may serve as a new therapeutic target for cocaine addiction using brain stimulation techniques, such as transcranial magnetic stimulation (TMS).

More about this paper on PubMed

A figure from this study
A figure from this study

hot off the press!

Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia.

Neuron. 2017 Jul 19;95(2):341-356.e6. doi: 10.1016/j.neuron.2017.06.020. Epub 2017 Jul 6.

De Biase LM, Schuebel KE, Fusfeld ZH, Jair K, Hawes IA, Cimbro R, Zhang HY, Liu QR, Shen H, Xi ZX, Goldman D, Bonci A.

Microglia play critical roles in tissue homeostasis and can also modulate neuronal function and synaptic connectivity. In contrast to astrocytes and oligodendrocytes, which arise from multiple progenitor pools, microglia arise from yolk sac progenitors and are widely considered to be equivalent throughout the CNS. However, little is known about basic properties of deep brain microglia, such as those within the basal ganglia (BG)....

More about this paper on PubMed

A figure from this study
A figure from this study

hot off the press!

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.

Science. 2017 Aug 4;357(6350):503-507. doi: 10.1126/science.aan2475.

Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M.

Designer receptors exclusively activated by designer drugs (DREADDs) constitute a powerful chemogenetic strategy that can modulate nerve cell activity in freely moving animal preparations. NIDA scientists used radioligand receptor occupancy measurements and in vivo positron emission tomography to show that DREADDs expressed in the brain are not activated by the designer compound CNO. Instead, they are activated by the CNO metabolite clozapine, a drug with multiple endogenous targets. This may have important implications for the interpretation of results obtained with this popular technology.

More about this paper on PubMed

Elise Lesage
Elise Lesage

hot off the press!

Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.

JAMA Psychiatry. 2017 Jun 1;74(6):632-640. doi: 10.1001/jamapsychiatry.2017.0400.

Lesage E, Aronson SE, Sutherland MT, Ross TJ, Salmeron BJ, Stein EA.

In this paper, NIDA scientists wanted to answer the question: ”How are reward sensitivity, in brain regions thought to be involved in drug abuse, and cognitive flexibility affected by acute abstinence and stimulation of the nicotinic acetylcholine receptors in dependent smokers?” In this placebo-controlled crossover study they found a “double dissociation” between decreased neural signatures of reward sensitivity...

More about this paper on PubMed

Study authors Study authors Haiying Zhang, Zheng-Xiong Xi, and Guohua Bi.
Haiying Zhang, Zheng-Xiong Xi, Guohua Bi.
Featured paper of the Month!

The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic

Neuropsychopharmacology. 2017 Aug;42(9):1871-1883. doi: 10.1038/npp.2017.41. Epub 2017 Mar 7.

Zhang HY, Bi GH, Yang HJ, He Y, Xue G, Cao J, Tanda G, Gardner EL, Newman AH, Xi ZX.

JJC8-016, a recently discovered (±) modafinil analogue and atypical dopamine transporter (DAT) inhibitor, was compared to R-modafinil for its effects in several rodent models of psychostimulant abuse. Strikingly, pretreatment with JJC8-016 dose-dependently inhibited cocaine-enhanced locomotion, cocaine self-administration, and cocaine-induced reinstatement of drug-seeking behavior, while R-MOD inhibited cocaine-induced reinstatement only at the high dose of 100 mg/kg. Notably, JJC8-016 alone neither altered extracellular dopamine in the nucleus accumbens nor maintained self-administration. It also failed to induce reinstatement of drug-seeking behavior ...

More about this paper on PubMed

Study authors Vikek Kumar and Amy Moritz.
Vikek Kumar and Amy Moritz.
Featured paper of the Month!

July 2017 - Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R).

J Med Chem. 2017 Feb 23;60(4):1478-1494. doi: 10.1021/acs.jmedchem.6b01688. Epub 2017 Feb 10.

Kumar V, Moritz AE, Keck TM, Bonifazi A, Ellenberger MP, Sibley CD, Free RB, Shi L, Lane JR, Sibley DR, Newman AH.

The development of bitopic ligands directed toward D2-like receptors has proven to be of particular interest to improve the selectivity and/or affinity of these ligands and as an approach to modulate and bias their efficacies. The structural similarities between dopamine D3 receptor (D3R)-selective molecules that display bitopic or allosteric pharmacology and those that are simply competitive antagonists are subtle and intriguing...

More about this paper on PubMed

Photo of 2017 Mentoring Award winners (left to right): Geoffrey Schoenbaum, MD, PhD (Investigator Award); Lindsay De Biase, PhD (Postdoctoral Fellow Award); and Karran Phillips, MD (Staff Clinician Award).
2017 Mentoring Awardees

NIDA IRP NEWS!

Congratulations to the 2017 NIDA IRP Mentoring Award winners.

Award recipients are (left to right): Geoffrey Schoenbaum, MD, PhD (Investigator Award); Lindsay De Biase, PhD (Postdoctoral Fellow Award); and Karran Phillips, MD (Staff Clinician Award). They were presented with plaques at the 6th annual NIDA Poster Day and Mentoring Awards Ceremony on May 17, 2017.

The Mentoring Awards recognize individuals who have served as exceptional mentors to trainees in the institute, and are given annually in the spring.

More about our Research Training program here


Health and Human Services Logo National Institute on Drug Abuse Logo


The National Institute on Drug Abuse (NIDA), is part of the National Institutes of Health (NIH), the principal biomedical and behavioral research agency of the United States Government. NIH is a component of the U.S. Department of Health and Human Services.

PDF documents require the free Adobe Reader. Microsoft Word documents require the free Microsoft Word viewer. Microsoft PowerPoint documents require the free Microsoft PowerPoint viewer. Flash content requires the free Adobe Flash Player.